SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 1, 2007
-----------
Date of Report (date of earliest event reported)
BIOMERICA, INC.
---------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-8765 95-2645573
-------- ------ ----------
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification Number)
Incorporation)
1533 Monrovia Avenue
Newport Beach, California 92663
-------------------------------
(Address of Principal Executive Offices
Including Zip Code)
949-645-2111
------------
(Registrant's Telephone Number,
Including Area Code)
______________
(Former Name or Former Address if Changed
Since Last Report)
Page 1 of 2 pages
Item 5.02 Election of Directors.
The Board of Directors of Biomerica, Inc. voted to elect Jane F.
Emerson, M.D., Ph.D. to serve on the board of directors of the Company effective
May 1, 2007. Dr. Emerson is a Clinical Professor and serves as the Chief of
Clinical Pathology and Vice Chair of the Department of Pathology and Laboratory
Medicine at the University of California, Irvine.
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: May 1, 2007 Biomerica, Inc.
By: /s/ Zackary S. Irani
--------------------
Zackary S. Irani
Chief Executive Officer